for the GEM Study Group IMPORTANCE We previously reported that survival is poorer from histopathologically amelanotic than pigmented melanoma because of more advanced stage at diagnosis. Identifying patients at risk of amelanotic melanoma might enable earlier diagnosis and improved survival; however, the phenotypic characteristics and underlying genetics associated with amelanotic melanoma are unknown.
A melanotic melanoma is defined as melanoma without pigment on inspection 1 or lacking melanin on histopathologic examination. 2 Approximately 2% to 8% of melanomas are amelanotic. 3 In the international, population-based, Genes, Environment, and Melanoma (GEM) study, 2 we reported that survival is poorer from amelanotic than pigmented melanoma due to more advanced stage at diagnosis. Studies examining patient characteristics associated with amelanotic melanoma have been limited to demographic and genotypic descriptions. 1, [4] [5] [6] [7] Amelanotic melanoma was associated with older age in GEM 2 and other studies, 1, 4 and predominantly found in white patients. 1, 4 Associations with sex have been less consistent as previously discussed for GEM. 2 Patients with amelanotic melanoma have been reported to carry MC1R variants linked to red hair (R) 5 and/or MITF E318K. 6 A study of 118 melanomas found MC1R R variants positively associated with amelanotic cases. 7 Our goal was to compare phenotype, MC1R status, and history of amelanotic melanoma between amelanotic and pigmented melanoma patients.
Methods

Population
The GEM study included 3579 patients with incident primary cutaneous melanoma from 1998 to 2003 at 8 sites in Australia, Canada, Italy, and the United States. 8 Institutional review boards at each center reviewed and approved the study. Patients gave written, informed consent. GEM ascertained data for incident (index) and prior melanomas from cancer registries. This report includes 2387 (66.7% of 3579) GEM participants with data for phenotype, MC1R genotyping, and melanomas scored for histopathologic pigmentation. Of these 2387 patients with incident melanomas scored for pigmentation, 527 had prior primary melanomas also scored for histopathologic pigmentation. According to GEM protocol, in situ melanomas were incident melanomas if patients had prior invasive melanomas. Self-administered questionnaires and telephone interviews were used to ascertain melanoma risk factors.
8 Back nevi were counted by family using glossy colored guides to aid nevus identification. 8 MC1R was sequenced from DNA from buccal swabs. 9 As in Taylor et al, 10 variants were classified as conferring higher risk for melanoma based on strong association with red hair phenotype (R: D84E, R142H, R151C, R160W, and D294H, all nonsense and insertion/deletions), lower risk for melanoma based on weaker association with red hair phenotype (r: all other nonsynonymous variants); or wildtype with absence of any variants (wt: consensus). Histopathologic pigmentation was determined by observation of melanin granules on light microscopy during centralized review of diagnostic slides for both index and prior primary melanomas. 2 We previously reported that histopathologic pigmentation scoring had moderate interobserver agreement (κ = 0.48) and a significant association with clinical, prebiopsy impression of pigmentation from pathology reports. 2 A scalar phenotypic index was derived by combining hair color, eye color, and ability to tan as previously described. 11 This index was dichotomized to indicate sun-resistant (scores of 0, 1, or 2) and sun-sensitive (scores of 3, 4, or 5) phenotypes.
Statistical Analysis
Among participants with incident single primary melanoma (SPM) or multiple primary melanoma (MPM), we estimated the odds ratios (OR) and 95% CIs for associations of phenotypic characteristics (freckles, nevi, phenotypic index) and MC1R status using logistic regression models adjusted for study design features: age, sex, study center, and lesion status (SPM or index MPM). Multivariable models were developed including the 3 phenotypic characteristics alone or with MC1R status to identify factors independently associated with amelanotic melanoma. The same analyses with individual phenotypic characteristics and separated MC1R genotypes were also performed. Association of histopathologic pigmentation between incident and prior melanomas for patients with MPM was analyzed using exact logistic regression. Association with MITF E318K mutations was also analyzed using exact logistic regression. Statistical tests were 2 sided with P < .05 considered significant. Data were analyzed using STATA version 13 (StataCorp LP).
Results
Overall, 178 (7.5% of 2387) incident and 32 (6.1% of 527) prior primary melanomas were amelanotic ( Table 1) .
Phenotypic Characteristics and MC1R Variants
In 2387 participants with incident melanomas ( 
Key Points
Question Are phenotypic characteristics, MC1R variants, and prior amelanotic melanoma associated with amelanotic melanoma?
Findings In this analysis of population-based and cancer-based registries, absence of back nevi, presence of many freckles, a sun-sensitive phenotype, and prior amelanotic melanoma were associated with development of amelanotic melanoma. MC1R was associated with amelanotic melanoma, but this association lost significance in a model with phenotype.
Meaning Prior amelanotic melanoma and the phenotypes associated with it should raise clinician index of suspicion for amelanotic melanoma when examining a suspicious but nonpigmented skin lesion, and clinicians might also use these characteristics to prompt periodic, meticulous screening of nonpigmented as well as pigmented skin lesions.
Including the phenotypic characteristics in 1 multivariable model, absence of back nevi (OR, 1.71, 95% CI, 1.14-2.57; P = .01), presence of many freckles (OR, 1.58; 95% CI, 1.04-2.39; P = .03), and a sun-sensitive phenotypic index (OR, 1.48; 95% CI, 1.07-2.07; P = .02) were significantly associated with amelanotic melanoma.
Adding MC1R to the multivariable model of phenotypic characteristics, absence of back nevi (OR, 1.68; 95% CI, 1.12-2.53; P = .01) and a sun-sensitive phenotypic index (OR, 1.44; 95% CI, 1.03-2.01; P = .03) remained statistically significant but not presence of many freckles or MC1R. Attenuation of the association with MC1R was explained by the addition of freckles and phenotypic index to the model. Despite the attenuation, the point estimate for the r/r, R/r, R/R variants was similar to that for freckling and phenotypic index.
Results for individual phenotypic characteristics and separate MC1R genotypes are in eTable 1 in the Supplement; eTable 2 in the Supplement shows that MITF E318K was not associated with amelanotic melanoma in our study (OR, 0.86; 95% CI, 0.22-2.37; P = .82). Table 3 shows associations of incident amelanotic melanoma with the pigmentation state of the previous melanoma in 527 participants with MPM and pigmentation scored for each melanoma. Of 24 patients with incident amelanotic melanomas, 5 (20.8%) had prior amelanotic melanomas. For 503 patients with incident pigmented melanomas, 27 (5.4%) had prior amelanotic melanomas. Patients with an incident amelanotic melanoma were more likely to have a prior amelanotic melanoma than those with an incident pigmented melanoma (OR, 4.62; 95% CI, 1.25-14.13; P = .01).
Incident and Prior Melanoma Pigmentation
Discussion
Our findings suggest that patients with prior amelanotic melanomas remain at risk of pigmented melanoma, but have increased odds of developing subsequent amelanotic melanomas. Further, we found independent associations of absence of back nevi, presence of many freckles, and a sunsensitive phenotypic index with amelanotic melanoma.
MC1R, a genetic determinant of phenotype (especially freckling and red hair), 9 was also associated with amelanotic melanoma. This association lost statistical significance in a model with phenotype, but the point estimate for the r/r, R/r, R/R variants was similar to that for the correlated phenotype variables. Thus, the association of MC1R with amelanotic melanoma may not be entirely accounted for by phenotype. Although clinicians may expect that patients with sunsensitive phenotypes or history of amelanotic melanoma are more likely to develop amelanotic melanoma, we are unaware of another study examining amelanotic melanoma's associations with phenotype or prior amelanotic melanoma. One report consistent with GEM described a Data are given as number (percentage) of melanomas unless otherwise specified. Counts do not sum to the total number of study subjects due to missing data.
b Other includes acral lentiginous, spindle cell, nevoid, and Spitzoid melanomas.
Research Brief Report Amelanotic Melanoma, MC1R Status, and Prior Amelanotic Melanoma 3 amelanotic melanomas in a patient with red hair, fair skin, many freckles, and few nevi. 6 Also similar to GEM, Ghiorzo et al 7 found an association of MC1R with amelanotic melanoma.
Strengths and Limitations
Strengths of our study include the large, international, population-based study design; centralized dermatopathology review; and objective definition of pigmentation. A limitation is that melanoma pigmentation may be misclassified due to interobserver variability. While we did not have prebiopsy pigmentation, we previously reported that the clinical, prebiopsy impression of pigmentation extracted from pathology reports was significantly associated with histopathologic pigmentation in a subset of GEM patients.
2
Conclusions
Increased index of suspicion for melanoma in presenting nonpigmented lesions and careful periodic screening for signs of amelanotic and pigmented melanoma in patients at increased odds of amelanotic melanoma might lead to a Data are given as number (percentage) of melanomas unless otherwise specified.
b Adjusted for study design features: sex, age, study center, and lesion status (SPM or index MPM).
c Adjusted for study design features, freckling, back moles, and phenotypic index.
d Adjusted for study design features and all characteristics displayed in the Table. e P values were calculated according to logistic regression models and P values for trend were calculated including MC1R categories as ordinal variables.
f Phenotypic index was calculated by additively combining hair color (black or dark brown = 0; light brown or blonde = 1; red = 2), eye color (brown = 0; gray, green, or hazel = 1; blue = 2), and ability to tan (deeply or moderately = 0; occasionally or none = 1). Those with index scores of 0, 1, or 2 were categorized as having a sun-resistant phenotypic index. Patients with index scores of 3, 4, or 5 were categorized as having a sun-sensitive phenotypic index. 15. Han J, Kraft P, Nan H, et al. A genome-wide association study identifies novel alleles associated with hair color and skin pigmentation. PLoS Genet. 2008;4(5):e1000074.
NOTABLE NOTES
Dysmorphophobia and the Wolf Man
Neelam A. Vashi, MD; Mayra B. C. Maymone, MD Body dysmorphic disorder (BDD) is characterized by an impairing preoccupation with a perceived defect in appearance that is not observable or appears very slight to others. Although BDD was only recently formally recognized, dysmorphophobia has a long history in psychiatry, dating back to the 19th century. Dysmorphia is a Greek word meaning ugliness, specifically of the face, and first appeared in the Histories of Herodotus referring to the myth of the ugliest girl in Sparta. Although being commonly used for nearly a century, the term dysmorphophobia is actually a misnomer because BDD is not a truly phobic condition. Not just a reflection of modern-day preoccupation with beauty and appearance, BDD is a chronic and often severe psychiatric illness that lies along a spectrum, ranging from mild to life-threatening symptoms.
In 1891, a description of this disorder was initially documented by the Italian psychiatrist Enrico Morselli, who named it dysmorphophobia. 1 Years later, in 1903, French psychiatrist Pierre Janet made the next major historical reference to dysmorphophobia, describing a married woman who had been housebound for 5 years because of her belief that she had a mustache. Janet, like Morselli, classified dysmorphophobia as belonging to a class of syndromes similar to obsessive-compulsive disorder, terming it l'obsession de la hontu du corps, or obsession with shame of the body.
One of the best-known cases in the history of BDD is that of a patient of Sigmund Freud, who went by the pseudonym "Wolf Man," later known to be Sergei Pankejeff, a wealthy Russian aristocrat. In his later life, Pankejeff became fixated with his nose, which led him to repeatedly seek out the opinions of physicians for "blackheads, swellings, wounds from picking pimples, and imaginary scars." 2 This fixation led him to pursue treatments and at one point, he complained that his nose had been disfigured as a result of a dermatologist's improper use of electrolysis, causing a hole and scar in his nose. Although many persons with BDD are delusional, Pankejeff did have the understanding that while the injury was noticeable to him, his reaction to it was abnormal. Therefore, he sought help through psychoanalyses after exhausting all his dermatological resources.
In modern-day society, many public figures have been thought to possibly have BDD, including author Franz Kafka, pop artist Andy Warhol, and singer Shirley Manson.
3 Becoming widely publicized, it has even been featured in the Music Television (MTV) series True Life, in an episode entitled "I Hate My Face." Dysmorphophobia, now more appropriately termed body dysmorphic disorder, can be a devastating, socially isolating disorder that can lead to suicide. With increasing visibility and recognition, there is hope that stigma related to disease will be diminished and patients will encounter fewer barriers to seek treatment. e P values were calculated according to logistic regression models and P values for trend were calculated including MC1R categories as ordinal variables. f MC1R ÒRÓ: D84E, R142H, R151C, R160W, and D294H, all nonsense and insertion/deletion; ÒrÓ: all other variants; ÒwtÓ: consensus.
Abbreviations: CI, confidence interval; GEM, genes, environment, and melanoma; MC1R, melanocortin 1 receptor; MPM, multiple primary melanoma; OR, odds ratio; SPM, single primary melanoma. Patients with missing data for MITF E318K mutation status (n=26) were excluded.
